TLDR Avalanche Foundation is raising $1 billion to launch a digital asset treasury company. The funds will be used to purchase AVAX tokens at a discounted price. Hivemind Capital and Dragonfly Capital are leading the two major investment deals. The first deal worth $500 million is expected to finalize by the end of the month. [...] The post Avalanche Foundation Seeks $1B to Launch AVAX Treasury Initiative appeared first on CoinCentral.TLDR Avalanche Foundation is raising $1 billion to launch a digital asset treasury company. The funds will be used to purchase AVAX tokens at a discounted price. Hivemind Capital and Dragonfly Capital are leading the two major investment deals. The first deal worth $500 million is expected to finalize by the end of the month. [...] The post Avalanche Foundation Seeks $1B to Launch AVAX Treasury Initiative appeared first on CoinCentral.

Avalanche Foundation Seeks $1B to Launch AVAX Treasury Initiative

TLDR

  • Avalanche Foundation is raising $1 billion to launch a digital asset treasury company.
  • The funds will be used to purchase AVAX tokens at a discounted price.
  • Hivemind Capital and Dragonfly Capital are leading the two major investment deals.
  • The first deal worth $500 million is expected to finalize by the end of the month.
  • The second deal, also for $500 million, is expected to close in October.

The Avalanche Foundation is seeking to raise $1 billion to establish a digital asset treasury company. The nonprofit plans to use the funds to purchase AVAX tokens at a discounted price. Industry sources revealed that the foundation aims to launch this project soon.

The $1 billion raise will involve two significant deals with prominent blockchain investors. Hivemind Capital, a New York-based investment firm, is leading one deal worth $500 million. The other deal is with Dragonfly Capital and will also raise $500 million, focusing on a special purpose acquisition vehicle.

Two Deals Set to Drive $1B Raise for AVAX Treasury

Sources familiar with the situation confirmed that Avalanche is finalizing two deals to fund its AVAX treasury project. The first deal will likely conclude by the end of this month. It involves a private placement led by Hivemind Capital, with Anthony Scaramucci advising on the deal.

The second deal is expected to close in October. It is led by Dragonfly Capital, a key player in the blockchain investment world. Both firms plan to purchase AVAX tokens from the Avalanche Foundation at a discounted price, aiming to fuel the growth of the AVAX treasury.

Avalanche’s $1B Strategy to Boost AVAX Scarcity

Avalanche plans to use the raised funds to accumulate AVAX tokens and establish a treasury. At current prices, $1 billion would buy about 34.7 million AVAX, roughly 8% of the total circulating supply. This strategy aims to increase the value of AVAX over time by securing a substantial amount of tokens.

The limited supply of 720 million AVAX further strengthens this strategy. Avalanche’s approach mirrors that of other major cryptocurrencies, like Bitcoin, which also has a capped supply. By consolidating tokens, Avalanche hopes to boost scarcity and enhance its long-term value.

The post Avalanche Foundation Seeks $1B to Launch AVAX Treasury Initiative appeared first on CoinCentral.

Market Opportunity
Avalanche Logo
Avalanche Price(AVAX)
$12.35
$12.35$12.35
-0.88%
USD
Avalanche (AVAX) Live Price Chart
Disclaimer: The articles reposted on this site are sourced from public platforms and are provided for informational purposes only. They do not necessarily reflect the views of MEXC. All rights remain with the original authors. If you believe any content infringes on third-party rights, please contact [email protected] for removal. MEXC makes no guarantees regarding the accuracy, completeness, or timeliness of the content and is not responsible for any actions taken based on the information provided. The content does not constitute financial, legal, or other professional advice, nor should it be considered a recommendation or endorsement by MEXC.

You May Also Like

Trump Media & Crypto.com Partner For Shareholder Token Airdrop

Trump Media & Crypto.com Partner For Shareholder Token Airdrop

Trump Media & Technology Group (NASDAQ:DJT) has announced plans to distribute a new digital token to its shareholders, leveraging Crypto.com‘s infraread more
Share
Coinstats2026/01/01 00:23
Tria’s $20m beta surge: How a self-custodial neobank is redefining onchain finance

Tria’s $20m beta surge: How a self-custodial neobank is redefining onchain finance

CEO Vijit Katta shares with crypto.news how Tria is reshaping digital asset banking and paving the way for a frictionless, user-controlled financial future.
Share
Crypto.news2026/01/01 01:00
The FDA Is Trying To Make Corporate Free Speech Situational

The FDA Is Trying To Make Corporate Free Speech Situational

The post The FDA Is Trying To Make Corporate Free Speech Situational appeared on BitcoinEthereumNews.com. BENSENVILLE, ILLINOIS – SEPTEMBER 10: Flanked by U.S. Attorney General Pam Bondi (rear), and FDA Commissioner Marty Makary (R), Secretary of Health and Human Services Robert F. Kennedy Jr. speaks to the press outside Midwest Distribution after it was raided by federal agents on September 10, 2025 in Bensenville, Illinois. According to the company, various e-liquids were seized in the raid. (Photo by Scott Olson/Getty Images) Getty Images While running for President in 2008, Barack Obama famously chanted “Yes we can.” Love or hate his political views, Obama’s politics were quite effective. He was asking voters to think big, to envision a much better future. Advertisers no doubt approved. That’s because ads routinely evoke things not as they are, but as they could be. Gyms and exercise equipment companies don’t promote their locations and equipment with flabby, lumbering people, rather their ads show fit, upright, energetic individuals. A look ahead. Restaurants do the same with ads showing happy people enjoying impressively put together plates of food. Conversely, ads meant to convince smokers to quit have not infrequently shown the worst of the worst future downsides of the habit. The nature of advertising comes to mind as FDA commissioner Marty Makary puzzlingly brags that “The Trump Administration Is Taking On Big Pharma” in the New York Times. Makary laments pharmaceutical ads that “are filled with dancing patients, glowing smiles and catch jingles that drown out the fine print.” Not explained is whether Makary would be happier if drug companies placed ads with immobile patients, frowns, and funereal music. Seriously, what does he expect? Does he want drug companies to commit billions to drug development to accompany their achievements with imagery defined by misery? Has Makary stopped to contemplate the myriad shareholders lawsuits drugmakers would face if, upon risking staggering sums meant…
Share
BitcoinEthereumNews2025/09/18 06:29